BioLife Solutions BLFS
$0.00 +$0.00 (0.00%)
Market closed · Oct 22, 12:40 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap$1.89B
P/E (TTM)32.7
Dividend yield–
Earnings
Average move on report day±10.7%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+42.8%
Worst reaction-28.7%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q1 | 7 May 2026 | After Market | ±22.7% | -4.67% | Within range |
| 2025/Q4 | 26 Feb 2026 | After Market | ±23.1% | +7.65% | Within range |
| 2025/Q3 | 6 Nov 2025 | After Market | ±22.3% | -4.03% | Within range |
| 2025/Q2 | 7 Aug 2025 | After Market | ±18.6% | +9.88% | Within range |
| 2025/Q1 | 8 May 2025 | After Market | ±15.2% | +4.16% | Within range |
| 2024/Q4 | 3 Mar 2025 | Pre Market | ±24.5% | +2.13% | Within range |
| 2024/Q3 | 12 Nov 2024 | After Market | ±13.6% | -9.02% | Within range |
| 2024/Q2 | 8 Aug 2024 | After Market | ±14.2% | +11.04% | Within range |
| 2024/Q1 | 9 May 2024 | After Market | ±14.3% | +8.50% | Within range |
| 2023/Q4 | 29 Feb 2024 | After Market | ±15.6% | +6.33% | Within range |
| 2023/Q3 | 9 Nov 2023 | None | ±14.3% | -3.86% | Within range |
| 2023/Q2 | 8 Aug 2023 | After Market | ±10.7% | -28.71% | Bigger than priced |
| 2023/Q1 | 10 May 2023 | After Market | ±21.0% | -1.93% | Within range |
| 2022/Q4 | 16 Mar 2023 | After Market | ±19.7% | +7.71% | Within range |
| 2022/Q3 | 9 Nov 2022 | After Market | ±15.0% | +42.77% | Bigger than priced |
| 2022/Q2 | 9 Aug 2022 | After Market | ±18.0% | +18.77% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$28.47M+21.5% YoY
Operating profit$1.70M+110.5% YoY
Net profit$45.10M+384.8% YoY
Diluted EPS$0.91+375.8% YoY
Free cash flow$5.19M-7.8% YoY
Operating cash flow$6.35M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin63.6%
Operating margin1.6%
Net margin54.3%
Return on equity15.1%
Return on assets13.9%
Return on invested capital14.4%
Current ratio9.69
Liabilities / assets6.1%
Cash & investments$82.42M
Total debt$13.15M
Net cash (debt)$69.27M
No comments yet — be the first to weigh in on BLFS.
Sign in to join the discussion.